VYNE Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYNE and other ETFs, options, and stocks.

About VYNE

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. 

CEO
David Domzalski
CEODavid Domzalski
Employees
13
Employees13
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
2011
Founded2011
Employees
13
Employees13

VYNE Key Statistics

Market cap
9.04M
Market cap9.04M
Price-Earnings ratio
-0.39
Price-Earnings ratio-0.39
Dividend yield
—
Dividend yield—
Average volume
1.83M
Average volume1.83M
High today
$0.373
High today$0.373
Low today
$0.35
Low today$0.35
Open price
$0.365
Open price$0.365
Volume
1.16M
Volume1.16M
52 Week high
$4.30
52 Week high$4.30
52 Week low
$0.2805
52 Week low$0.2805

People also own

Based on the portfolios of people who own VYNE. This list is generated using Robinhood data, and it’s not a recommendation.
NIO
SNDL
Bionano Genomics
Castor Maritime
Lucid Group
Workhorse
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.